Lynne Sullivan

Lynne currently chairs the Audit Committees of Solid Bioscience, ResTORbio, BiomX, and Inozyme Pharma. She was most recently CFO of Compass Therapeutics, a Cambridge based Immuno Oncology company, and was SVP of Finance at Biogen, where she spent over a decade, with global responsibility for Corporate Finance, Financial Planning and Analysis and Corporate Tax. Formerly, Lynne was the Vice President of Tax for EMD Serono and the Vice President of Tax for North America at Merck KgaA. She was also a Tax Partner at Arthur Anderson, where she led the North East Region’s Tax Consulting Practice for the firm. Lynne holds a B.S. in Accounting from Suffolk University and a M.S. in Taxation from Bentley College. She served as the Co-Chair of BIO’s Finance and Tax Committee from 2007 through 2018 and was a Certified Public Accountant licensed in MA from 1991 through June of 2018.